Histogenics, a biotech developing an implantable tissue repair platform for cartilage damage to the knee, filed on Tuesday with the SEC to raise up to $65 million in an initial public offering. The company's lead candidate, NeoCart, uses a patient's own...read more
This week's 10 IPOs largely disappointed as 70% were forced to price below the proposed range and 80% closed the week up 1% or less. Before this week, only 36% of IPOs this year had first-day pops of 1% or less. The enthusiasm for last week's ...read more
Innocoll, which develops absorbable collagen drugs to treat pain, foot infections and adhesions, raised $59 million by offering 6.5 million ADSs (upsized from 5.4 million) at $9, below the range of $13 to $15. Insiders were expected to purchase $27 million (46%...read more
Need knee repair? Histogenics files for a $65 million IPO
Histogenics, a biotech developing an implantable tissue repair platform for cartilage damage to the knee, filed on Tuesday with the SEC to raise up to $65 million in an initial public offering. The company's lead candidate, NeoCart, uses a patient's own...read more
US IPO Pricing Recap: The crazy chicken flies while 8 IPOs trade down or flat
This week's 10 IPOs largely disappointed as 70% were forced to price below the proposed range and 80% closed the week up 1% or less. Before this week, only 36% of IPOs this year had first-day pops of 1% or less. The enthusiasm for last week's ...read more
Innocoll prices IPO at $9, below the range
Innocoll, which develops absorbable collagen drugs to treat pain, foot infections and adhesions, raised $59 million by offering 6.5 million ADSs (upsized from 5.4 million) at $9, below the range of $13 to $15. Insiders were expected to purchase $27 million (46%...read more
14 US IPOs planned for the week of Jul 21
The following IPOs are expected to price this week: Advanced Drainage Systems (WMS), the world's largest provider of high density plastic pipe used in construction,...read more